Viva Biotech Holdings (HKG: 1873)
Hong Kong
· Delayed Price · Currency is HKD 0.600
-0.020 (-3.23%)
Sep 10, 2024, 3:59 PM HKT
Viva Biotech Holdings Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 9, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Market Capitalization | 1,285 | 2,249 | 3,352 | 9,045 | 17,492 | 7,122 | Upgrade
|
| Market Cap Growth | -60.49% | -32.91% | -62.94% | -48.29% | 145.61% | - | Upgrade
|
| Enterprise Value | 1,842 | 4,227 | 5,809 | 10,494 | 15,958 | 5,762 | Upgrade
|
| Last Close Price | 0.60 | 1.05 | 1.75 | 4.71 | 9.13 | 4.54 | Upgrade
|
| PE Ratio | - | -6.66 | -5.53 | 46.45 | -30.75 | 22.53 | Upgrade
|
| PS Ratio | 0.57 | 0.95 | 1.25 | 3.50 | 21.13 | 19.71 | Upgrade
|
| PB Ratio | 0.32 | 0.55 | 0.82 | 1.88 | 3.92 | 3.58 | Upgrade
|
| P/FCF Ratio | 309.59 | 10.43 | 21.69 | -15.12 | -26.81 | -625.63 | Upgrade
|
| P/OCF Ratio | 4.84 | 5.32 | 7.68 | 94.67 | 341.10 | 138.37 | Upgrade
|
| EV/Sales Ratio | 0.86 | 1.78 | 2.16 | 4.06 | 19.28 | 15.95 | Upgrade
|
| EV/EBITDA Ratio | 4.40 | 9.81 | 11.78 | 23.11 | 81.76 | 72.77 | Upgrade
|
| EV/EBIT Ratio | 9.28 | 19.91 | 19.32 | 36.09 | 119.40 | 94.83 | Upgrade
|
| EV/FCF Ratio | 443.73 | 19.61 | 37.58 | -17.54 | -24.46 | -506.22 | Upgrade
|
| Debt / Equity Ratio | 0.41 | 0.52 | 0.78 | 0.68 | 0.79 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | 3.96 | 4.71 | 6.25 | 6.81 | 16.25 | 0.56 | Upgrade
|
| Debt / FCF Ratio | 398.92 | 9.72 | 20.65 | -5.45 | -5.40 | -4.86 | Upgrade
|
| Asset Turnover | 0.26 | 0.28 | 0.30 | 0.26 | 0.14 | 0.27 | Upgrade
|
| Inventory Turnover | 5.26 | 4.84 | 5.61 | 7.33 | 4.53 | 24.90 | Upgrade
|
| Quick Ratio | 1.27 | 1.03 | 0.44 | 1.44 | 3.75 | 13.73 | Upgrade
|
| Current Ratio | 1.65 | 1.32 | 0.73 | 2.14 | 4.56 | 15.00 | Upgrade
|
| Return on Equity (ROE) | 0.83% | -2.74% | -13.41% | 7.84% | -13.69% | 26.21% | Upgrade
|
| Return on Assets (ROA) | 1.51% | 1.57% | 2.08% | 1.83% | 1.40% | 2.80% | Upgrade
|
| Return on Capital (ROIC) | 1.94% | 2.00% | 2.56% | 2.23% | 1.64% | 2.95% | Upgrade
|
| Earnings Yield | -16.16% | -5.69% | -17.82% | 3.90% | -2.63% | 4.18% | Upgrade
|
| FCF Yield | 0.32% | 9.59% | 4.61% | -6.61% | -3.73% | -0.16% | Upgrade
|
| Dividend Yield | 0.00% | - | - | - | 0.30% | 0.45% | Upgrade
|
| Payout Ratio | 0.00% | - | - | 5.66% | - | 5.67% | Upgrade
|
| Buyback Yield / Dilution | -7.22% | -5.91% | 2.81% | -25.41% | -5.83% | -24.72% | Upgrade
|
| Total Shareholder Return | -7.22% | -5.91% | 2.81% | -25.41% | -5.53% | -24.28% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.